Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis. (Q51717478)
Jump to navigation
Jump to search
scientific article published in August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis. |
scientific article published in August 2010 |
Statements
1 reference
Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis. (English)
1 reference
Vincent Meininger
1 reference
Joseph Verheijde
1 reference
Mohammed Sanjak
1 reference
Francois Salachas
1 reference
Elizabeth Frija-Orvoen
1 reference
Paul Theys
1 reference
Duncan Hutchinson
1 reference
Thomas Pianta
1 reference
Heather Stewart
1 reference
Benjamin Rix Brooks
1 reference
Patrice Douillet
1 reference
Xaliproden [SR57746A] ALS International Study Group
1 reference
1 August 2010
1 reference
11
1 reference
4
1 reference
383-388
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference